statements

Lactose (India) Ltd.

BSE: 524202

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

100.40-3.1 (-3.00%)

21 Aug, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Lactose (India) Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS	12M IR
Total Revenue	40.06	46.85	22.24	23.69	34.45	35.66	31.10	40.61	40.05	34.96	45.94	65.80	113.89	116.40	163.29	170.68
Cost of Operating Revenue	30.29	37.56	12.10	10.80	14.56	8.76	9.28	11.31	10.88	9.53	12.14	29.02	80.23	82.60	125.57	130.60
Gross Profit	9.77	9.28	10.14	12.89	19.90	26.90	21.82	29.30	29.17	25.43	33.80	36.78	33.66	33.80	37.72	40.09
Gross Margin	24.4	19.8	45.6	54.4	57.8	75.4	70.2	72.2	72.8	72.7	73.6	55.9	29.6	29.0	23.1	23.5
Total Operating Expenses	38.22	45.42	23.50	20.51	27.40	27.68	29.08	34.61	34.69	33.10	38.24	59.03	100.11	104.83	150.66	157.27
Operating Profit	1.84	1.42	-1.25	3.19	7.06	7.98	2.03	6.00	5.36	1.86	7.70	6.77	13.78	11.57	12.63	13.41
Operating Margin	4.6	3.0	-5.6	13.5	20.5	22.4	6.5	14.8	13.4	5.3	16.8	10.3	12.1	9.9	7.7	7.9
Financing Income/(Expense) - Net	-0.65	-0.33	-0.59	-2.66	-4.42	-4.46	-5.46	-5.35	-5.56	-5.45	-5.12	-6.04	-5.24	-6.10	-5.09	-5.63
Profit before Taxes	1.03	1.40	0.05	0.86	3.88	4.37	-2.77	1.07	0.10	-3.27	3.17	1.46	9.66	6.92	8.62	9.56
Income Taxes	0.34	0.42	0.03	0.36	1.08	1.59	-1.44	0.35	0.03	-0.79	0.71	0.26	2.88	1.75	2.56	2.63
Profit after Tax	0.69	0.97	0.03	0.50	2.80	2.78	-1.33	0.72	0.07	-2.48	2.45	1.21	6.79	5.16	6.06	6.93
PAT Margin	1.7	2.1	0.1	2.1	8.1	7.8	-4.3	1.8	0.2	-7.1	5.3	1.8	6.0	4.4	3.7	4.1
EPS - Basic - ex Extraordinary Items	0.95	1.34	0.03	0.60	3.30	2.88	-1.37	0.71	0.07	-2.40	2.10	0.96	5.39	4.10	4.82	5.50
EPS - Diluted - ex Extraordinary Items	0.95	1.34	0.03	0.60	3.30	2.88	-1.37	0.71	0.07	-2.40	2.10	0.96	5.39	4.10	4.68	5.45
EBIT	1.84	1.42	-1.25	3.19	7.06	7.98	2.03	6.00	5.36	1.86	7.70	6.77	13.78	11.57	12.63	13.41
EBITDA	3.49	3.20	1.17	5.13	10.40	11.36	5.59	9.61	9.27	6.22	12.26	11.46	19.00	16.96	18.38	19.42
EBITDA Margin	8.7	6.8	5.3	21.7	30.2	31.9	18.0	23.7	23.1	17.8	26.7	17.4	16.7	14.6	11.3	11.4

Balance Sheet

Abridged

Understanding Balance Sheet

Lactose (India) Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	R 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	18.84	19.69	12.96	12.57	17.43	17.48	16.92	17.69	19.81	19.70	22.75	37.40	35.53	57.33	98.62
Long-Term Investments	0.66	0.66	0.56	0.56	2.19	2.16	2.13	0.87	1.16	4.85	5.21	0.00	0.00	0.00	0.00
Property Plant & Equipment - Net	15.56	25.94	43.33	63.64	63.23	63.48	62.13	61.87	62.02	62.96	59.20	56.06	54.60	62.51	69.29
Total Non-Current Assets	17.30	27.13	47.40	67.08	66.76	67.59	65.64	63.98	64.19	68.64	67.47	63.89	65.21	76.14	84.61
Total Assets	36.14	46.81	60.35	79.65	84.19	85.07	82.56	81.67	84.00	88.34	90.22	101.29	100.74	133.47	183.23
Total Current Liabilities	12.79	17.18	15.75	19.82	25.99	27.35	12.60	12.11	11.41	11.63	14.91	26.47	25.40	44.89	89.80
Long Term Debt	1.29	4.71	19.55	28.76	22.53	19.63	34.02	31.50	34.91	39.59	34.49	32.65	24.88	25.93	23.35
Total Non-Current Liabilities	10.39	15.01	29.58	43.94	35.99	30.98	38.20	35.32	38.31	41.63	36.03	34.26	28.24	29.84	28.64
Total Liabilities	23.18	32.19	45.33	63.76	61.98	58.33	50.79	47.42	49.72	53.26	50.94	60.73	53.64	74.73	118.44
Total Shareholders' Equity	12.95	14.62	15.02	15.89	22.21	26.74	31.76	34.25	34.29	35.09	39.28	40.56	47.10	58.74	64.79
Total Equity	12.95	14.62	15.02	15.89	22.21	26.74	31.76	34.25	34.29	35.09	39.28	40.56	47.10	58.74	64.79
Total Liabilities & Equity	36.14	46.81	60.35	79.65	84.19	85.07	82.56	81.67	84.00	88.34	90.22	101.29	100.74	133.47	183.23

Cash Flow

Abridged

Understanding Cash Flow Statement

Lactose (India) Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	R 2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	C 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	R 2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	C 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	2.78	2.89	1.78	2.47	5.92	6.71	-0.50	3.92	4.07	1.31	7.86	6.14	13.73	10.92	13.26
Working Capital - Increase/(Decrease)	-6.56	11.35	4.72	7.83	-8.36	-3.20	-4.98	-4.12	-2.04	-4.44	-4.36	-4.16	-10.08	-16.42	-11.60
Net CF from Operating Activities	-3.78	14.24	6.50	10.30	-2.44	3.50	-5.48	-0.20	2.03	-3.13	3.50	1.98	3.65	-5.51	1.67
Capital Expenditures - Net	4.04	12.18	19.84	22.26	1.94	3.63	2.22	2.06	3.07	5.46	1.03	1.54	2.16	13.92	10.48
Net CF from Investing Activities	-3.11	-14.34	-21.50	-23.41	3.45	-4.83	-2.02	-2.02	-3.05	-6.33	-0.71	-0.98	-2.15	-15.64	-10.24
Stock - Issuance/(Retirement) - Net	-	0.40	0.38	0.36	1.73	1.73	6.28	1.78	-	3.23	1.81	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-0.82	2.76	14.36	10.57	-2.77	-0.49	3.84	-1.54	1.98	6.75	-4.84	-2.35	-0.89	24.10	4.62
Net Cash Flow from Financing Activities	7.11	0.97	14.40	12.59	-1.03	1.24	10.12	0.23	1.98	9.97	-3.03	-2.35	-0.54	24.10	4.62
Free Cash Flow to Equity	-8.64	4.82	1.01	-1.39	-7.14	-0.62	-3.86	-3.81	0.95	-1.85	-2.38	-1.90	0.60	4.68	-4.19
Free Operating CF net dividend	-7.94	2.04	-13.36	-11.96	-4.38	-0.18	-7.70	-2.26	-1.05	-8.62	2.17	0.42	1.46	-19.88	-8.82
Free Operating CF	-7.94	2.04	-13.36	-11.96	-4.38	-0.18	-7.70	-2.26	-1.05	-8.62	2.17	0.42	1.46	-19.88	-8.82

Business Segment Analysis

FY End:

Mar 25

Lactose (India) Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Pharmaceuticals (100.0%)₹ 14.38 Cr

Revenue / Sales

Pharmaceuticals (100.0%)₹ 116.40 Cr

Assets

Pharmaceuticals (100.0%)₹ 133.47 Cr

Operating Income

Pharmaceuticals (100.0%)₹ 11.57 Cr

Regional Segment Analysis

FY End:

Mar 12

Lactose (India) Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (81.1%)₹ 32.23 CrOutside India (18.9%)₹ 7.53 Cr

Assets

India (98.5%)₹ 38.35 CrOutside India (1.5%)₹ 0.60 Cr

Historical Segment Analysis

Track how Lactose (India) Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2025 Mar 31
	2025 Mar 31
Pharmaceuticals	14

Frequently Asked Questions

What is the revenue of Lactose (India) Ltd.?

The latest trailing twelve month revenue of Lactose (India) Ltd. is ₹ 170.68 Cr, reflecting a 1-year growth of 34.91% and a 3-year CAGR of 26.84%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Lactose (India) Ltd.?

The latest trailing twelve month net profit (PAT) of Lactose (India) Ltd. is ₹ 6.06 Cr, with a 3-year earnings CAGR of 69.55%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Lactose (India) Ltd.?

The trailing twelve month EBITDA of Lactose (India) Ltd. is approximately ₹ 13.21 Cr (based on an operating margin of 7.74%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Lactose (India) Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Lactose (India) Ltd. is 4.68. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Lactose (India) Ltd.?

The debt-to-equity ratio of Lactose (India) Ltd. stands at 0.96. The interest coverage ratio is 2.48x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Lactose (India) Ltd.?

The estimated book value per share of Lactose (India) Ltd. is 51.47 (derived from a P/B ratio of 1.95 and market price of ₹ 100.40), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Lactose (India) Ltd.?

The trailing twelve month operating cash flow of Lactose (India) Ltd. is ₹ 1.67 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Lactose (India) Ltd. report consolidated or standalone financials?

Lactose (India) Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.